Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives

BACKGROUND: In the treatment of Non-Small Cell Lung Cancer (NSCLC) the combination of Immuno- Oncotherapy (IO) and chemotherapy (CT) has been found to be superior to IO or CT alone for patients’ survival. Patients and clinicians are confronted with a preference sensitive choice between a more aggres...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveri, Serena, Lanzoni, Lucilla, Veldwijk, Jorien, de Wit, G. Ardine, Petrocchi, Serena, Janssens, Rosanne, Schoefs, Elise, Smith, Meredith Y., Smith, Ian, Nackaerts, Kristiaan, Vandevelde, Marie, Louis, Evelyne, Decaluwé, Herbert, De Leyn, Paul, Declerck, Hanne, Petrella, Francesco, Casiraghi, Monica, Galli, Giulia, Garassino, Marina Chiara, Girvalaki, Charis, Huys, Isabelle, Pravettoni, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325723/
https://www.ncbi.nlm.nih.gov/pubmed/37425173
http://dx.doi.org/10.3389/fpsyg.2023.1062830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325723/
https://www.ncbi.nlm.nih.gov/pubmed/37425173
http://dx.doi.org/10.3389/fpsyg.2023.1062830

Ejemplares similares